RSV Vaccine in Transplant Recipients

Clinical trial NCT06593210 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06593210
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Vaccine Response Impaired Respiratory Syncytial Virus Infections Immune Suppression

Start date: 2024-10-01
Primary completion: 2026-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.